Prognostic significance of tumor DNA content in carcinoma of the hepatic duct confluence

Journal of Experimental and Clinical Cancer Research

Volumn 17, Issue 4, 1998, Pages 425-430

  Iachino, C ^b,d   Catsicojannis, N ^a   Dallera, F ^c  

^a Anticancer Oncologic Hosp S Savas   (Greece)

^b UNIVERSITY OF GENOA   (Italy)

^c Maggiore Hospital   (Italy)

^d NONE   (Italy)

Author keywords

Aneuploid pattern; DNA; Klatskin tumor; Radiotherapy

Indexed keywords

DNA; IRIDIUM 192;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; DIPLOIDY; DNA CONTENT; FEMALE; FLOW CYTOMETRY; HEPATIC DUCT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KLATSKIN TUMOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ADULT; AGED; ANEUPLOIDY; BILE DUCT NEOPLASMS; DIPLOIDY; DNA, NEOPLASM; FEMALE; GENETIC MARKERS; HEPATIC DUCT, COMMON; HUMANS; KLATSKIN'S TUMOR; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

EID: 0032419938     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Klatskin G.: Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. Am. J. Med. 38: 241-256, 1965.
2. Boerma E.J.: Research into the rsults of resection of hilar bile duct cancer. Surgery 108: 572-580, 1990.
3. Lees C.D., Zapolanski A., Cooperman A.M., Herman R.E.: Carcinoma of the bile ducts. Surg. Gynec. Obstet. 151: 193-198, 1980.
4. Lai E.C.S., Tompkins R.K., Rosylin J.J., Mann L.L.: Proximal bile duct cancer. Ann. Surg. 205: 111-118, 1987.
5. Ellis C.N., Burnette J.J., Sedlak R., Dyas C., Blakemore W.S.: Prognostic application of DNA analysis in solid malignant lesions in humans. Surg. Gynec. Obstet. 173: 329-342, 1991.
6. Verbeek P.C.M., van Leeuwen D.J., van der Heyde M.N., Gonzalez D.: Does additive radiotherapy after hilar resection improve survival of cholangiocarcinoma? Ann. Chir. 45: 350-354, 1990.
7. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J. Histochem. Cytochem. 31: 1333-1335, 1983.
8. Vindelov LL, Chrinstensen IJ, Nissen NI. A detergent-tripsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323-327, 1983.
9. van der Linder J.C., Lindeman J., Baak J.P.A., Meijer C.J.L.M., Herman C.J.: The multivariate prognostic index and nuclear DNA content are independent prognostic factors in primary breast cancer patients. Cytometry 10: 56-61, 1989.
10. Kaplan E.L., Meier P.: Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53: 457-481, 1958.
11. Mantel N., Haenszel W.: Statistical aspects of the analysis of data from retrospective studies of diseases. J Natl Cancer Inst 22: 719-748, 1959.
12. Cox D.R.: Regression models and life tables. J. R. Stat. Soc. Britain. 34: 187-200, 1972.
13. Cornelisse C.J., van de Velde C.J.H., Caspers R.J.C., Moolenaar A.J., Hermans J.: DNA ploidy and survival in breast cancer patients. Cytometry 8: 225-234, 1987.
14. Kokal W.A., Gardine R.L., Sheibani K. et al.: Tumor DNA content in resectable, primary colorectal carcinoma. Ann. Surg. 209: 188-193, 1989.
15. Alanen K.A., Joensuu H., Klemi P.J., Nevalainen T.J.: Clinical significance of nuclear DNA content in pancreatic carcinoma. J. Pathol. 160: 313-320, 1990.
16. Bosma A.: Surgical pathology of cholangiocarcinoma of the liver hilus (Klatskin tumor). Semin. Liver Dis. 10: 85-90, 1990.
17. Sato Y., Tanaka J., Yoshioka H., Koyama K.: Evaluation of the malignancy in gallbladder cancer assessed by nuclear DNA contents and mitotic indices. J. Jpn Surg. Soc. 92: 46-51, 1991.
18. Vindelov L.L., Hansen H.H., Chrinstensen I.J. et al.: Clinical heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow cytometric DNA analysis. Cancer Res. 40: 4295-4300, 1980.
19. Tompkins R.K., Thomas D., Wile A., Longmire W.P.: Prognostic factors in bile duct carcinoma. Ann. Surg. 194: 447-457, 1981.
20. Beazley R.M., Hadjis N., Benjamin I.S., Blumgart L.H.: Clinico-pathological aspects of high bile duct cancer. Ann. Surg. 199: 623-636, 1984.
21. Ouchi K., Suzuki M., Hashimoto L., Sato T.: Histologic findings and prognostic factors in carcinoma of the upper bile duct. Am. J. Surg. 157: 552-556, 1989.
22. Friedlander M.L., Hedley D.W., Taylor I.W., Russell P., Coates A.S., Tattersall M.H.N.: Influence of cellular DNA content on survival in advanced ovarian cancer. Cancer Res. 44: 397-400, 1984.
23. Mizumoto R., Kawarada Y., Suzuki H.: Surgical treatment of hilar carcinoma of the bile duct. Surg. Gynec. Obstet. 162: 153-158, 1986.
24. Koyama K., Tanaka J., Kato S., Asanuma Y.: New strategy for treatment of carcinoma of the biliar duct. Surg. Gynec. Obstet. 168: 523-530, 1989.
25. Koyama K., Tanaka J., Sato Y., Seki H., Kato Y., Umezawa A.: Experience in twenty patients with carcinoma of hilar bile duct treated with "new strategy" - resection, targeting chemotherapy and intracavitary irradiation. Surg. Gynec. Obstet. (in press).
26. Yu J.M., Zhang H., Wang S.Q. et al.: DNA ploidy analysis of effectiveness of radiation therapy for cervical carcinoma. Cancer 68: 76-78, 1991.
27. Emdin S.O., Stenling R., Roos G.: Prognostic value of DNA content in colorectal carcinoma: A flow cytometric study with some methodologic aspects. Cancer 60: 1282-1287, 1987.